Measured Wealth Private Client Group, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1720235
PORTSMOUTH, NH
Position in BMY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,520,798
+$1,184,590 QoQ
Shares Held
25,075
+302.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Measured Wealth Private Client Group, LLC holds $3,974,731 across 13 Drug Manufacturers - General names. BMY ranks #1 (38.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
This page
|
25,075 | $1,520,798 | |
| 2 | JNJ |
Johnson & Johnson
|
3,336 | $815,451 | |
| 3 | ABBV |
AbbVie Inc.
|
2,142 | $465,863 | |
| 4 | AMGN |
Amgen Inc
|
905 | $318,424 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,518 | $302,890 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,072 | $288,774 | |
| 7 | LLY |
ELI LILLY & Co
|
114 | $104,853 | |
| 8 | PFE |
Pfizer Inc
|
2,283 | $64,106 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,520,798 | 25,075 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $336,208 | 6,233 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $409,327 | 9,076 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $661,391 | 14,288 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,236,084 | 20,267 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $631,435 | 11,164 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $285,294 | 5,514 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $234,063 | 5,636 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $343,601 | 6,336 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $325,100 | 6,336 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $325,952 | 5,616 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $450,591 | 7,046 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $488,358 | 7,046 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $506,959 | 7,046 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $498,838 | 7,017 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $478,709 | 6,217 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $454,027 | 6,217 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $387,629 | 6,217 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $367,859 | 6,217 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $477,295 | 7,143 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $450,937 | 7,143 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $442,087 | 7,127 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $643,957 | 10,681 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $654,502 | 11,131 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $526,018 | 9,437 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||